$辉瑞 (PFE.US)$ and its partner BioNTech announced Thursday evening that they will seek authorization from the FDA for a third "booster" dose of their COVID vaccines that will offer increased protection against the Delta variant (despite the fact that both Pfizer and its rival Moderna repeatedly insisted that its vaccines are still effective against all known variants including Delta). The company referenced the data out of Israel, where government scientists have estimated the real efficacy of the vaccine vs. Delta is somewhere around 64%, while leaving particularly vulnerable patients at risk of severe illness and death. The booster dose would ideally be given within 6 to 12 months post-vaccination. The news is surprisingly aggressive, considering the FDA hasn't even approved the first generation of vaccines yet (they were all granted emergency authorizations, and the FDA is still evaluating safety data, which is why we know the mRNA jabs cause rare side effects including heart inflammation in a small number of men). The CDC and FDA will decide whether to recommend a third dose. But they have a pretty strong track record of safeguarding the interests of the Big Pharma companies that produced the vaccines. And when asked about getting the vaccine shot i’ll tell them the same thing i tell my wife “Keep that thing away from me!”
...

嘿！mooer们，
你们的假期过得怎么样？
欢迎回到我的课堂~
老实说，你知道做出明智的投资决策最重要的事情是什么吗？
当然信息!!!
在开始交易之前，您必须收集大量关于公司、宏观市场甚至交易的详细信息，以获取自己的想法。
moomoo让您的投资更加轻松，尤其在信息收集方面提供了帮助。...

周三，在全天波动之后，美国三大股指收盘接近历史新高，此前美联储的会议纪要显示，官员们正在就缩减资产购买规模进行辩论，经济不确定性继续升高。
那个 $标普500指数 (.SPX.US)$和 $道琼斯指数 (.DJI.US)$上涨了0.3％， $纳斯达克综合指数 (.IXIC.US)$会议大致持平。
周三交易量最高的10只美国股票
...